Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,625 people get ONXX articles and Market Currents by email alert.
Get email alerts on ONXX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Marketwire (May 8, 2013)
-
Marketwire (May 7, 2013)
-
-
-
Marketwire (Apr 16, 2013)
-
-
-
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
Onyx Pharmaceuticals: Profit Ramp AheadWilliam Meyers • Mon, Jan 7 -
-
-
-
-
3 Reasons To Buy Onyx PharmaceuticalsMarkus Aarnio • Sun, May 27, 2012
-
Onyx Pharmaceutical: Highest Returning Protected Covered CallMike Phillips • Thu, Apr 26, 2012 -
Onyx's Myeloma Drug Shifts To The Slow LaneEP Vantage • Tue, Dec 13, 2011 -
Onyx: Deal Or No Deal, Time For A PayoffProhost Biotech • Tue, Nov 29, 2011 -
Onyx Pharma's Prospects Look BrightWilliam Meyers • Thu, Aug 18, 2011
-
Higher-Than-Expected Loss at OnyxZacks Investment Research • Thu, May 5, 2011 -
Onyx Pharma's Future Getting BrighterZacks Investment Research • Fri, Mar 18, 2011
-
-
-
-
Onyx Pharmaceuticals Inc. Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
Onyx Pharmaceuticals Inc. Q1 2009 Earnings Call TranscriptWed, May 6, 2009
-
Onyx Pharmaceuticals, Inc., Q4 2008 Earnings Call TranscriptMon, Mar 2, 2009
-
ONYX Pharmaceuticals, Inc. Q3 2008 Earnings Call TranscriptFri, Nov 7, 2008
-
Onyx Pharmaceuticals Inc. Q2 2008 Earnings Call TranscriptTue, Aug 5, 2008
-
Onyx Pharmaceuticals Inc. Q1 2008 Earnings Call TranscriptTue, May 6, 2008
-
Onyx Pharmaceuticals Inc., Q4 2007 Earnings Call TranscriptTue, Feb 19, 2008
-
Onyx Pharmaceuticals Q3 2007 Earnings Call TranscriptTue, Nov 6, 2007
-
Marketwire (May 8, 2013)
-
Marketwire (May 7, 2013)
-
Marketwire (Apr 16, 2013)
-
Marketwire (Feb 27, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 5, 2013)
-
Marketwire (Jan 16, 2013)
-
Marketwire (Jan 15, 2013)
-
at CNBC.com (Jan 13, 2013)
-
at CNBC.com (Jan 7, 2013)
-
at CNBC.com (Jan 7, 2013)
-
Marketwire (Jan 2, 2013)
-
Marketwire (Dec 17, 2012)
ONXX vs. ETF Alternatives
Company Description
We are a biopharmaceutical company dedicated to developing innovative therapies that target the molecular mechanisms that cause cancer. Through our internal research programs and in conjunction with our collaborators, we are applying our expertise to develop and commercialize therapies designed... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 4:02 PM Onyx Pharma (ONXX): Q1 EPS of -$0.19 beats by $0.30. Revenue of $145.5M beats by $11.14M. Shares +2.3% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Tuesday, May 7, 12:10 AM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Monday, May 6, 5:35 PM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Monday, March 25, 5:24 PM Bayer HealthCare and Onyx Pharmaceuticals (ONXX) say the Ministry of Health, Labor and Welfare in Japan has approved Stivarga tablets for the treatment of patients with metastatic colorectal cancer. The drug was approved in the U.S. by the FDA in September 2012. Comment! [Healthcare, Global & FX]
- Monday, March 11, 9:34 AM The National Comprehensive Cancer Network (NCCN) adds the combination of carfilzomib, which is sold by Onyx Pharmaceuticals (ONXX), lendalidomide (made by Celgene (CELG)) and dexamethasone to its guidelines as an option for treating multiple myeloma patients who are also transplant candidates. The NCCN also adds carfilzomib monotherapy and other agents as a preferred treatment regimen for salvage therapy. The FDA hasn't approved carfilzomib for these uses, so Onyx won't market carfilzomib for them. Comment! [Healthcare]
- Thursday, February 21, 4:02 PM Onyx Pharma (ONXX): Q4 EPS of -$0.36 beats by $0.40. Revenue of $127.9M beats by $14.73M. Shares +3.5% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Thursday, February 21, 12:10 AM Notable earnings after Thursday’s close: ACTG, AIG, ARUN, ATLS, BMRN, BV, CENX, CLGX, COG, CUBE, CYH, DRYS, EXEL, EXR, FIRE, FLS, FTR, GDI, HPQ, INT, INTU, ITMN, JWN, MRVL, NEM, NPSP, ONXX, PSA, SBAC, SWN, TS, WBMD Comment! [Earnings]
- Wednesday, February 20, 5:35 PM Notable earnings after Thursday’s close: ACTG, AIG, ARUN, ATLS, BMRN, BV, CENX, CLGX, COG, CUBE, CYH, DRYS, EXEL, EXR, FIRE, FLS, FTR, GDI, HPQ, INT, INTU, ITMN, JWN, MRVL, NEM, NPSP, ONXX, PSA, SBAC, SWN, TS, WBMD 2 Comments [Earnings]
-
Thursday, January 17, 5:40 PM
After-hours top gainers, as of 5:15 p.m.: AM +9%. ARAY +4%. SOXS +3%. EGLE +3%. ONXX +2%.
After-hours top losers: COF -8%. TSRX -6%. PATH -5%. INTC -4%. MAKO -3%. Comment! [On the Move] - Tuesday, January 15, 5:41 PM Onyx Pharmaceuticals (ONXX) announces a 4.4M share secondary offering with a 30-day option to purchase up to an additional 660K shares to cover over-allotments, if any. The offering is expected to close by January 22, 2013, and the company intends to use the net proceeds to fund its clinical development programs, R&D, and sales and marketing activities to globally commercialize Kyprolis. BofA Merrill Lynch and Barclays are co-book runners. Shares -2% AH. Comment! [Healthcare, On the Move]
- Thursday, January 3, 11:23 AM Bayer (BAYRY.PK) and Onyx Pharmaceuticals (ONXX +0.3%) say that Phase 3 trials of Nexavar tablets in patients with locally advanced or metastatic thyroid cancer has met its primary endpoint showing a statistically significant improvement in survival when compared to a placebo. The data is expected to be presented in an upcoming JPMorgan Healthcare Conference. Comment! [Healthcare]
- Thursday, November 1, 2012, 4:06 PM ONYX Pharmaceuticals (ONXX): Q3 EPS of -$0.79 beats by $0.11. Revenue of $89.5M (+19% Y/Y) beats by $9M. Shares +2.2% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
- Thursday, November 1, 2012, 12:10 AM Notable earnings after Thursday’s close: AIG, AIV, ALSK, ATML, BKD, BMR, CAR, CENX, CHK, DCT, DDR, DWA, EIX, EQIX, FLR, FSLR, GLUU, HAIN, HIG, HTGC, INT, ITMN, JMBA, JOE, KERX, KOG, LIFE, LLNW, LNC, LNKD, LVS, MDLZ, MELI, MNKD, NEM, NGD, NKTR, NLY, OMPI, ONNN, ONXX, OPEN, PBI, PCLN, ROVI, RSG, SAM, SBUX, SHO, SKUL, SPWR, SWKS, SWN, TRIP, UNTD, VNO, VRTX, WBMD, WIT, WPRT, YELP, ZAGG, ZIOP Comment! [Earnings]
- Wednesday, October 31, 2012, 5:35 PM Notable earnings after Thursday’s close: AIG, AIV, ALSK, ATML, BKD, BMR, CAR, CENX, CHK, DCT, DDR, DWA, EIX, EQIX, FLR, FSLR, GLUU, HAIN, HIG, HTGC, INT, ITMN, JMBA, JOE, KERX, KOG, LIFE, LLNW, LNC, LNKD, LVS, MDLZ, MELI, MNKD, NEM, NGD, NKTR, NLY, OMPI, ONNN, ONXX, OPEN, PBI, PCLN, ROVI, RSG, SAM, SBUX, SHO, SKUL, SPWR, SWKS, SWN, TRIP, UNTD, VNO, VRTX, WBMD, WIT, WPRT, YELP, ZAGG, ZIOP Comment! [Earnings]
- Tuesday, October 30, 2012, 12:10 AM Notable earnings scheduled for Tuesday afternoon: ACPW, BNNY, CAR, CBG, CENX, DVA, DWA, EA, EQIX, FISV, GERN, GNW, HTGC, ITRI, IVR, JDSU, KIM, LGCY, MIPS, MWA, OKE, OKS, ONXX, PPO,PSMT, QEP, QUIK, SIMG, SSW, STR, STX, TRIP, TTWO, WMB, WPZ, WU Comment! [Earnings]
- Monday, October 29, 2012, 5:35 PM Notable earnings after Tuesday’s close: ACPW, BNNY, CAR, CBG, CENX, DVA, DWA, EA, EQIX, FISV, GERN, GNW, HTGC, ITRI, IVR, JDSU, KIM, LGCY, MIPS, MWA, OKE, OKS, ONXX, PPO,PSMT, QEP, QUIK, SIMG, SSW, STR, STX, TRIP, TTWO, WMB, WPZ, WU Comment! [Earnings]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Brian L. Wilson
$CELG $MDVN $ONXX $REGN $TLON.OB - 5 companies with newly approved cancer drugs to watch next year http://seekingalpha.com/a/mc3t - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 1 replies
-
-
freefdawatchlist
http://bit.ly/ObIXDN New Upcoming FDA approval list for 2012 - 2013 $KIPS, $OMER, /4HEB, $BMTI, $PATH, $ONXX, $GSK, $POZN - View all 1 replies
-
